Condition: Mature B-Cell Neoplasm · Non Hodgkin Lymphoma · DLBCL · Sponsor: Schrödinger, Inc.
The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD) and/or recommended dose (RD) of SGR-1505.
This description comes directly from the study's public registry record.
Study Physician · +1 (503)-922-0158 · sdgr-trials-group@schrodinger.com
Always discuss trial participation with your own doctor first.
| Banner Health - MD Anderson Cancer Center | Gilbert, Arizona, United States | Recruiting |
| Christiana Care Hospital - Helen F Graham Cancer Center | Newark, Delaware, United States | Recruiting |
| Napa Research | Pompano Beach, Florida, United States | Recruiting |
| Beth Israel Deaconess Medical Center | Boston, Massachusetts, United States | Recruiting |
| Regional Cancer Care Associates | Hackensack, New Jersey, United States | Recruiting |
| Roswell Park Comprehensive Cancer Center | Buffalo, New York, United States | Recruiting |
| Weill Cornell | New York, New York, United States | Recruiting |
| Montefiore Medical Center | The Bronx, New York, United States | Recruiting |
| Duke University | Durham, North Carolina, United States | Recruiting |
| Gabrail Cancer & Research Center | Canton, Ohio, United States | Recruiting |
| The Ohio State University - The James Cancer Hospital | Columbus, Ohio, United States | Recruiting |
| Oregon Health and Science University - Knight Cancer Institute | Portland, Oregon, United States | Recruiting |
+ 24 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05544019